Rhodiola comprises several species of plants in the Crassulacea family and is generally found in the arctic mountain regions of Siberia. The root of the plant is used medicinally and is also known as "Arctic root" or "Golden root" and more recently as “Crenulin”. Rhodiola has been used for hundreds of years to treat cold and flu-like symptoms, promote longevity and increase the body’s resistance to physical and mental stresses.
Rhodiola is typically considered to be an “adaptogen” and is believed to invigorate the body and mind to increase resistance to a multitude of stresses. The key active constituents in Rhodiola are believed to be rosavin, rosarin, rosin and salidroside.
Rhodiola rosea extract is thought to be quite safe. There are no known contraindications or interactions with other drugs/herbs, but there is some potential for allergic reactions in some individuals.

Function:

1. Enhancing immunity and delaying aging;

2. Resisting radiation and tumor;

3. Regulating nervous system and metabolism, effectively limiting melancholy feeling and mood, and promoting mental status;

4. Protecting cardiovascular, dilating coronary artery, preventing coronary arteriosclerosis and arrhythmia.  

Application:

1. Applied in food fields, it is widely used as functional food additive;
2. Applied in health product field, it can be used as raw material in health food, the purpose is to enhance immunity and resist melancholy;
3. Applied in cosmetics fields, it is widely used to delay aging and compact skin;
4. Applied in pharmaceutical field, it is widely used to treat cardio-cerebrovascular disease.

For more product information pls kindly contact email sales09@staherb.cn

Product Analysis

 References:

1. 1.Perfumi M., Mahioli L., Adaptogenic and CNS effects on single dose of 3% rosavin and 1% salidroside Rhodiola rosea L. extract in mice, Phytother Res, 2007, 21, 37–43
2. 2.Qu ZQ., Zhou Y., Zeng YS., Li Y., Cheng Pl., Pretreatment with Rhodiola rosea extract reduces cognitive impairment induced by intracerebrovascular streptozotocin in rats: implication of anti-oxidative and neuroprotective effects, Biomedical and Enviromental Science, 2009, 22, 318–326
3. 3.Panossian A., Wilkman G., Sarris J., Rosenroot (Rhodiola rosea): traditional use, chemical composition, pharmacology and clinical efficacy, Phytomedicine, 2010, 7, 481–493
4. 4.Elamen A., Dragland S., Klemsdal SS., Bioactive compounds produced by clones of Rhodiola rosea maintained in the Norwegian germplasm collection, Pharmazie, 2010, 65, 618–23
5. 5.Staneva J., Todorova M., Neykov N., Evstatieva L,. Ultrasonically assisted extraction of total phenols and flavonoids from Rhodiola rosea, Natural Product Communications, 2009, 4, 935–938
6. 6.Khakpai F., Nasehi M., Haeri-Rohani A., Eidi A., Zarrindast MR., Scopolamine induced memory impairment; possible involvement of NMDA receptors mechanisms of dorsal hippocampus and/or septum, Behavioral Brain Research, 2012, 231, 1–10
7. 7.Park SJ., Kim DH., Jung JM., Kim JM., Cai M., Liu X., et al, The ameliorating effects of stigmasterol on scopolamine-induced memory impairments in mice, Europian Journal of Pharmacology, 2012, 676, 64–70
8. 8.Knox LT., Jing Y., Fleete MS., Collie VD., Zhang H., Liu P., Scopolamine impairs behavioral function and arginine metabolism in the rat dentate gyrus, Neuropharmacology, 2011, 61, 1452–1462
9. 9.Klinkenberg I., Blokland A., A comparison of scopolamine and biperiden as a rodent model for cholinergic cognitive impairment, Psychopharmacology (Berl), 2011, 15, 549–566
10. 10.Evstatieva L., Todorova M., Antonova D., Quality control of extracts of Rhodiola rosea L. based on the content of salidroside and rosavines, Proc, 5 CMAPSEEC, 2011, 208, 2–5
11. 11.Evstatieva L., Todorova M., Antonova D., Staneva J., Chemical composition of the essential oils of Rhodiola rosea L. of three different origins, Pharmacognosy Mag, 2010, 6, 256–258
12. 12.Kesner RP., Churchwell JC., An Analysis of rat prefrontal cortex in mediating executive functions, Neurobiol, Learn, Memory, 2011, 96, 417–31
13. 13.Shi TY., Feng SF., Xing JH., WU JM., Li XQ., Zhang N., et al, Neuroprotective effects of salidroside and its analogue tyrosol galactoside against focal cerebral ischemia in vivo and h(2)o (2)-induced neurotoxicity in vitro, Neurotox Res, 2012, 21, 358–367
14. 14.Tulsawani B., Meena DK., Shukla H., Sharma P., Meena RV., Gupta V., et al., Ninety days of repeated gavage administration of Rhodiola extract in rats, J Appl Toxicology, 2011, 10, 1009–1015
15. 15.Petkov VD., Yonkov D., Mosharoff A., Kambourova T., Alova L., Petkov VV., et al, Effects of alcohol aqueous extract from Rhodiola rosea L. roots on learning and memory, Acta Physiol Pharmacol Bulg, 1986, 12, 3–16
16. 16.Huang SC., Lee FT., Kuo TY., Yang JH., Chien CT., Attenuation of long-term Rhodiola rosea supplementation on exhaustive swimming evoked oxidative stress in the rat, Chin J Physiol, 2009, 52, 316–324
17. 17.Brito GH., Davis BJ., Stopp LC., Stanton NE., Memory and septo-hippocampal cholinergic system in the rat, Psychopharmacology (Berlin), 1983, 81, 315–20
18. 18.Falsafi SK., Deli A., Höger H., Pollak A., Lubec G., Scopolamine administration modulates muscarinic, nicotinic and NMDA receptor system, PLoS ONE, 2012, 7, e32082 
19. 19.Wiedenfield H., Dumaa M., Malinowski M., Furmanowa M., Naratuya S., Phytochemical and analytical studies of extracts from Rhodiola rosea and Rhodiola quadrifolia, Pharmazie, 2007, 64, 308–11.
20. 20.Edwards D., Heufelder A., Zimmermann A., Therapeutic effects and safety of Rhodiola rosea extract WS 1375 in subjects with life-stress symptoms-results of an open-label study, Phythother Res, 2012

21. Changsha Staherb Natural Ingredients Co.,ltd.

    Address: Room.202, Buliding B8, Huanchuang Enterprise Square, High-tech Development Zone, Changsha, Hunan, China(410205)   

    Contact:Mary

    Email: sales05@staherb.cn  sales@staherb.cn

    Tel :+86-(0)731-84213302   Fax：+86-(0)731-85953715

    Website:www.staherb.cn